Silk Road Medical/SILK

$21.93

1.85%
-
1D1W1MYTD1YMAX

About Silk Road Medical

Silk Road Medical, Inc. is a medical device company that is focused on reducing the risk of stroke and its impact. The Company has developed an approach for the treatment of carotid artery disease called TransCarotid Artery Revascularization (TCAR). TCAR is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a stroke. Its product portfolio consists of five single-use components: ENROUTE Transcarotid Neuroprotection System, ENROUTE Transcarotid Stent System, ENHANCE Transcarotid Peripheral Access Kit, ENROUTE 0.014'' Guidewire and ENROUTE Enflate Transcarotid RX Balloon Dilation Catheter. It manufactures ENROUTE NPS and ENROUTE NPS PLUS, or its ENROUTE NPS products, at its facilities in Sunnyvale, California and Plymouth, Minnesota. These facilities provide an aggregate of over 35,000 square feet of space for its production and distribution operations.

Ticker

SILK

Sector

Healthcare

Trading on

NASDAQ

Industry

Medical Equipment & Supplies

CEO

Charles McKhann

Employees

474

Headquarters

Sunnyvale, United States

SILK Metrics

BasicAdvanced
$865M
Market cap
-
P/E ratio
-$1.37
EPS
1.51
Beta
-
Dividend rate
$865M
1.51328
$34.13
$6.08
694K
11.046
9.617
51.523
51.523
-20.87%
-35.04%
-22.75%
4.663
5.872
5.873
23.04%
8.22%
33.04%

What the Analysts think about SILK

Analyst Ratings

Majority rating from 10 analysts.
Hold

Price Targets

Average projection from 6 analysts.
5.75% downside
High $28.00
Low $8.00
$21.93
Current price
$20.67
Average price target

SILK Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-29.13% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$48M
2.54%
Net income
-$14M
8.46%
Profit margin
-29.13%
5.77%

SILK Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 10.56%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.35
-$0.33
-$0.33
-$0.36
-
Expected
-$0.39
-$0.35
-$0.42
-$0.40
-$0.38
Surprise
-10.23%
-6.4%
-21.66%
-10.56%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for Silk Road Medical stock?

Silk Road Medical (SILK) has a market cap of $865M as of May 28, 2024.

What is the P/E ratio for Silk Road Medical stock?

The price to earnings (P/E) ratio for Silk Road Medical (SILK) stock is 0 as of May 28, 2024.

Does Silk Road Medical stock pay dividends?

No, Silk Road Medical (SILK) stock does not pay dividends to its shareholders as of May 28, 2024.

When is the next Silk Road Medical dividend payment date?

Silk Road Medical (SILK) stock does not pay dividends to its shareholders.

What is the beta indicator for Silk Road Medical?

Silk Road Medical (SILK) has a beta rating of 1.51. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

What is the Silk Road Medical stock price target?

The target price for Silk Road Medical (SILK) stock is $20.67, which is 5.75% below the current price of $21.93. This is an average based on projections from 6 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Silk Road Medical stock

Buy or sell Silk Road Medical stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing